Blimp1 activation by AP-1 in human lung cancer cells promotes a migratory phenotype and is inhibited by the lysyl oxidase propeptide

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Yu, Ziyang ^a   Sato, Seiichi ^a   Trackman, Philip C ^b   Kirsch, Kathrin H ^c   Sonenshein, Gail E ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; LYSYL OXIDASE PROPEPTIDE; PROTEIN C JUN; PROTEIN PRECURSOR; RAF PROTEIN; RAS PROTEIN; RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; PRDM1 PROTEIN, HUMAN; PRIMER DNA; PROTEIN LYSINE 6 OXIDASE; RECOMBINANT PROTEIN; REPRESSOR PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CANCER INHIBITION; CANCER INVASION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION; GENE SILENCING; GLIOBLASTOMA; HEAD AND NECK TUMOR; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MICROARRAY ANALYSIS; MIGRATION INHIBITION; PANCREAS ADENOCARCINOMA; PHENOTYPE; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; ANIMAL; CELL MOTION; CHEMISTRY; GENETICS; LUNG TUMOR; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROTEIN TERTIARY STRUCTURE; TUMOR CELL LINE;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CELL MOVEMENT; DNA PRIMERS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUNG NEOPLASMS; MICE; PHENOTYPE; PROMOTER REGIONS, GENETIC; PROTEIN STRUCTURE, TERTIARY; PROTEIN-LYSINE 6-OXIDASE; PROTO-ONCOGENE PROTEINS C-RAF; RAS PROTEINS; RECOMBINANT PROTEINS; REPRESSOR PROTEINS; RNA, NEOPLASM; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1;

EID: 84858246322     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033287     Document Type: Article

References (70)

1. Martins G, Calame K, (2008) Regulation and functions of Blimp-1 in T and B lymphocytes. Annu Rev Immunol 26: 133-169.
2. Ren B, Chee KJ, Kim TH, Maniatis T, (1999) PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins. Genes Dev 13: 125-137.
3. Keller AD, Maniatis T, (1991) Identification and characterization of a novel repressor of beta-interferon gene expression. Genes Dev 5: 868-879.
4. Gyory I, Wu J, Fejer G, Seto E, Wright KL, (2004) PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing. Nat Immunol 5: 299-308.
5. Yu J, Angelin-Duclos C, Greenwood J, Liao J, Calame K, (2000) Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase. Mol Cell Biol 20: 2592-2603.
6. Kuo TC, Calame KL, (2004) B lymphocyte-induced maturation protein (Blimp)-1, IFN regulatory factor (IRF)-1, and IRF-2 can bind to the same regulatory sites. J Immunol 173: 5556-5563.
7. Turner CA Jr, Mack DH, Davis MM, (1994) Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell 77: 297-306.
8. Shaffer AL, Lin KI, Kuo TC, Yu X, Hurt EM, et al. (2002) Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 17: 51-62.
9. Calame K, (2008) Activation-dependent induction of Blimp-1. Curr Opin Immunol 20: 259-264.
10. Kallies A, Hawkins ED, Belz GT, Metcalf D, Hommel M, et al. (2006) Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance. Nat Immunol 7: 466-474.
11. Ohinata Y, Payer B, O'Carroll D, Ancelin K, Ono Y, et al. (2005) Blimp1 is a critical determinant of the germ cell lineage in mice. Nature 436: 207-213.
12. Vincent SD, Dunn NR, Sciammas R, Shapiro-Shalef M, Davis MM, et al. (2005) The zinc finger transcriptional repressor Blimp1/Prdm1 is dispensable for early axis formation but is required for specification of primordial germ cells in the mouse. Development 132: 1315-1325.
13. Wang X, Belguise K, O'Neill CF, Sanchez-Morgan N, Romagnoli M, et al. (2009) RelB NF-kappaB represses estrogen receptor alpha expression via induction of the zinc finger protein Blimp1. Mol Cell Biol 29: 3832-3844.
14. Wang X, Belguise K, Kersual N, Kirsch KH, Mineva ND, et al. (2007) Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2. Nat Cell Biol 9: 470-478.
15. Yan J, Jiang J, Lim CA, Wu Q, Ng HH, et al. (2007) BLIMP1 regulates cell growth through repression of p53 transcription. Proc Natl Acad Sci U S A 104: 1841-1846.
16. Karnoub AE, Weinberg RA, (2008) Ras oncogenes: split personalities. Nat Rev Mol Cell Biol 9: 517-531.
17. Roberts PJ, Der CJ, (2007) Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26: 3291-3310.
18. Johnson L, Mercer K, Greenbaum D, Bronson RT, Crowley D, et al. (2001) Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410: 1111-1116.
19. Adiseshaiah P, Lindner DJ, Kalvakolanu DV, Reddy SP, (2007) FRA-1 proto-oncogene induces lung epithelial cell invasion and anchorage-independent growth in vitro, but is insufficient to promote tumor growth in vivo. Cancer Res 67: 6204-6211.
20. Adiseshaiah P, Vaz M, Machireddy N, Kalvakolanu DV, Reddy SP, (2008) A Fra-1-dependent, matrix metalloproteinase driven EGFR activation promotes human lung epithelial cell motility and invasion. J Cell Physiol 216: 405-412.
21. Eferl R, Wagner EF, (2003) AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3: 859-868.
22. Contente S, Kenyon K, Rimoldi D, Friedman RM, (1990) Expression of gene rrg is associated with reversion of NIH 3T3 transformed by LTR-c-H-ras. Science 249: 796-798.
23. Jeay S, Pianetti S, Kagan HM, Sonenshein GE, (2003) Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B. Mol Cell Biol 23: 2251-2263.
24. Shames DS, Girard L, Gao B, Sato M, Lewis CM, et al. (2006) A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies. PLoS Med 3: e486.
25. Wu M, Min C, Wang X, Yu Z, Kirsch KH, et al. (2007) Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells. Cancer Res 67: 6278-6285.
26. Woznick AR, Braddock AL, Dulai M, Seymour ML, Callahan RE, et al. (2005) Lysyl oxidase expression in bronchogenic carcinoma. Am J Surg 189: 297-301.
27. Csiszar K, Fong SF, Ujfalusi A, Krawetz SA, Salvati EP, et al. (2002) Somatic mutations of the lysyl oxidase gene on chromosome 5q23.1 in colorectal tumors. Int J Cancer 97: 636-642.
28. Ren C, Yang G, Timme TL, Wheeler TM, Thompson TC, (1998) Reduced lysyl oxidase messenger RNA levels in experimental and human prostate cancer. Cancer Res 58: 1285-1290.
29. Kaneda A, Wakazono K, Tsukamoto T, Watanabe N, Yagi Y, et al. (2004) Lysyl oxidase is a tumor suppressor gene inactivated by methylation and loss of heterozygosity in human gastric cancers. Cancer Res 64: 6410-6415.
30. Rost T, Pyritz V, Rathcke IO, Gorogh T, Dunne AA, et al. (2003) Reduction of LOX- and LOXL2-mRNA expression in head and neck squamous cell carcinomas. Anticancer Res 23: 1565-1573.
31. Trackman PC, Bedell-Hogan D, Tang J, Kagan HM, (1992) Post-translational glycosylation and proteolytic processing of a lysyl oxidase precursor. J Biol Chem 267: 8666-8671.
32. Palamakumbura AH, Jeay S, Guo Y, Pischon N, Sommer P, et al. (2004) The propeptide domain of lysyl oxidase induces phenotypic reversion of ras-transformed cells. J Biol Chem 279: 40593-40600.
33. Min C, Kirsch KH, Zhao Y, Jeay S, Palamakumbura AH, et al. (2007) The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer. Cancer Res 67: 1105-1112.
34. Min C, Yu Z, Kirsch KH, Zhao Y, Vora SR, et al. (2009) A loss-of-function polymorphism in the propeptide domain of the LOX gene and breast cancer. Cancer Res 69: 6685-6693.
35. Zhao Y, Min C, Vora SR, Trackman PC, Sonenshein GE, et al. (2009) The lysyl oxidase pro-peptide attenuates fibronectin-mediated activation of focal adhesion kinase and p130Cas in breast cancer cells. J Biol Chem 284: 1385-1393.
36. Palamakumbura AH, Vora SR, Nugent MA, Kirsch KH, Sonenshein GE, et al. (2009) Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling. Oncogene.
37. Shimizu K, Birnbaum D, Ruley MA, Fasano O, Suard Y, et al. (1983) Structure of the Ki-ras gene of the human lung carcinoma cell line Calu-1. Nature 304: 497-500.
38. Singh A, Greninger P, Rhodes D, Koopman L, Violette S, et al. (2009) A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival. Cancer Cell 15: 489-500.
39. Cordenonsi M, Montagner M, Adorno M, Zacchigna L, Martello G, et al. (2007) Integration of TGF-beta and Ras/MAPK signaling through p53 phosphorylation. Science 315: 840-843.
40. Tunyaplin C, Shaffer AL, Angelin-Duclos CD, Yu X, Staudt LM, et al. (2004) Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation. J Immunol 173: 1158-1165.
41. Wang X, Sonenshein GE, (2005) Induction of the RelB NF-kappaB subunit by the cytomegalovirus IE1 protein is mediated via Jun kinase and c-Jun/Fra-2 AP-1 complexes. J Virol 79: 95-105.
42. Romieu-Mourez R, Kim DW, Shin SM, Demicco EG, Landesman-Bollag E, et al. (2003) Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors. Mol Cell Biol 23: 5738-5754.
43. Freund A, Jolivel V, Durand S, Kersual N, Chalbos D, et al. (2004) Mechanisms underlying differential expression of interleukin-8 in breast cancer cells. Oncogene 23: 6105-6114.
44. Chadee DN, Kyriakis JM, (2004) MLK3 is required for mitogen activation of B-Raf, ERK and cell proliferation. Nat Cell Biol 6: 770-776.
45. Hurtado PA, Vora S, Sume SS, Yang D, St Hilaire C, et al. (2008) Lysyl oxidase propeptide inhibits smooth muscle cell signaling and proliferation. Biochem Biophys Res Commun 366: 156-161.
46. Desai S, Bolick SC, Maurin M, Wright KL, (2009) PU.1 regulates positive regulatory domain I-binding factor 1/Blimp-1 transcription in lymphoma cells. J Immunol 183: 5778-5787.
47. Vasanwala FH, Kusam S, Toney LM, Dent AL, (2002) Repression of AP-1 function: a mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 protooncogene. J Immunol 169: 1922-1929.
48. Ahmed SU, Milner J, (2009) Basal cancer cell survival involves JNK2 suppression of a novel JNK1/c-Jun/Bcl-3 apoptotic network. PLoS One 4: e7305.
49. Hou J, Aerts J, den Hamer B, van Ijcken W, den Bakker M, et al. (2010) Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS One 5: e10312.
50. Morris JPT, Wang SC, Hebrok M, (2010) KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. Nat Rev Cancer 10: 683-695.
51. Molinolo AA, Amornphimoltham P, Squarize CH, Castilho RM, Patel V, et al. (2009) Dysregulated molecular networks in head and neck carcinogenesis. Oral Oncol 45: 324-334.
52. Ohgaki H, Kleihues P, (2009) Genetic alterations and signaling pathways in the evolution of gliomas. Cancer Sci 100: 2235-2241.
53. Badea L, Herlea V, Dima SO, Dumitrascu T, Popescu I, (2008) Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. Hepatogastroenterology 55: 2016-2027.
54. Estilo CL, O-charoenrat P, Talbot S, Socci ND, Carlson DL, et al. (2009) Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis. BMC Cancer 9: 11.
55. Sun L, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, et al. (2006) Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 9: 287-300.
56. Choy E, Chiu VK, Silletti J, Feoktistov M, Morimoto T, et al. (1999) Endomembrane trafficking of ras: the CAAX motif targets proteins to the ER and Golgi. Cell 98: 69-80.
57. Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, et al. (1987) Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49: 729-739.
58. Khattar E, Kumar V, (2010) Mitogenic regulation of p27(Kip1) gene is mediated by AP-1 transcription factors. J Biol Chem 285: 4554-4561.
59. Yochum GS, Cleland R, Goodman RH, (2008) A genome-wide screen for beta-catenin binding sites identifies a downstream enhancer element that controls c-Myc gene expression. Mol Cell Biol 28: 7368-7379.
60. Vora SR, Palamakumbura AH, Mitsi M, Guo Y, Pischon N, et al. (2010) Lysyl oxidase propeptide inhibits FGF-2-induced signaling and proliferation of osteoblasts. J Biol Chem 285: 7384-7393.
61. Sato S, Trackman PC, Maki JM, Myllyharju J, Kirsch KH, et al. (2011) The Ras signaling inhibitor LOX-PP interacts with Hsp70 and c-Raf to reduce Erk activation and transformed phenotype of breast cancer cells. Mol Cell Biol 31: 2683-2695.
62. Blasco RB, Francoz S, Santamaria D, Canamero M, Dubus P, et al. (2011) c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma. Cancer Cell 19: 652-663.
63. Ozanne BW, Spence HJ, McGarry LC, Hennigan RF, (2007) Transcription factors control invasion: AP-1 the first among equals. Oncogene 26: 1-10.
64. Choi J, Choi K, Benveniste EN, Rho SB, Hong YS, et al. (2005) Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2. Cancer Res 65: 5554-5560.
65. Han S, Ritzenthaler JD, Sitaraman SV, Roman J, (2006) Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells. J Biol Chem 281: 29614-29624.
66. Ohkubo Y, Arima M, Arguni E, Okada S, Yamashita K, et al. (2005) A role for c-fos/activator protein 1 in B lymphocyte terminal differentiation. J Immunol 174: 7703-7710.
67. Chew LJ, Coley W, Cheng Y, Gallo V, (2010) Mechanisms of regulation of oligodendrocyte development by p38 mitogen-activated protein kinase. J Neurosci 30: 11011-11027.
68. Leppa S, Saffrich R, Ansorge W, Bohmann D, (1998) Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation. Embo J 17: 4404-4413.
69. Gruda MC, Kovary K, Metz R, Bravo R, (1994) Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity. Oncogene 9: 2537-2547.
70. Herbst RS, Heymach JV, Lippman SM, (2008) Lung cancer. N Engl J Med 359: 1367-1380.